Developed in conjunction with Joomla extensions.

Patents

Dr. Claudio Passananti
 
CNR patents, all active:
 
- Licensing agreement between CNR and ILIT Bio-Ventures/ Zingenix on 2014 (prot.CNR-IBPM n. 0001360 del 01/08/ 2014)
 
- Assignee: CNR. Inventors: C. Passananti, N. Corbi, M.G. Di Certo, E. Mattei, C. Pisani, G. Strimpakos, S. Luvisetto. 
Title: “Compositions and Methods for treatment of Muscular Dystrophy”. 
European Patent Application n. 14002611.3 (2014)
PCT/EP2015/066993 (2015)
U.S. Patent Application n. 15/328,833 (2017) 
International publication number: WO2016/016119 (2016)
 
- Assignee: CNR. Inventors: C. Passananti, Nicoletta Corbi, M.G. Di Certo, E. Mattei, C. Pisani, G Strimpakos. 
Title: “Vettore adeno-associato ricombinante muscolo-specifico e suo impiego nel trattamento di patologie muscolari”.
Italian patent application n. TO2013A000669 (2013). 
Title: “Compositions and Methods for treatment of Muscular Dystrophy”.
PCT/EP2014/002051 (2014) (originated from IP application n. TO2013A000669)
European Patent Application n. 14746954.8 (2014)
U.S. Patent Application n. 14/909,854 
International publication number: WO2015/018503 (2015)
 
- Assignee: CNR. Inventors: C. Passananti, M.G. Di Certo, A. Onori and N. Corbi. 
Title: “Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof.”
International publication number: WO2009044383( 2009)
Granted IT patent n. 1379230 on 30/08/2010
Granted EP patent n. 2193200 on 2011 from PCT/IB2008/054089 filed on 06/10/2008. Validated in France, Germany, UK, Italy.
Granted U.S. patent n. 8,304,235 on 2012
 
- Assignee: CNR. Inventors: N. Corbi, E. Mattei and C. Passananti.
Title: “Animale non umano transgenico per il gene sintetico zinc finger, regolatore trascrizionale dell’utrofina.”
Granted Italian patent n. 0001359932 on 21/03/2007
 


Dr. Veronica Morea
 
CNR Patent:
 
- Patent IT n° WO/2008/015720; International Application No.: PCT/IT2007/000551 (2008)
Assignee: CNR: Inventors: Morea V (CNR);Tramontano A, Soro S (Sapienza); D’Atri S, Failla CM, Lacal PM,  Orecchia A, Zambruno G (IDI-IRCCS)
Title: “Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1 having proangiogenic activity” 
 

 
Dr. Maria Patrizia Somma
 
CNR Patent:
 
- EU Application No. 12153511.6 – 1222 (March 2012)
Assignee: CNR, Inventors: Somma M.P., Gatti M (CNR), Di Cunto F., Provero P., Damasco C., Lembo A. (Università Torino)
Title: Markers to predict survival of breast cancer patients and uses thereof.
 


Dr. Enrico Cundari
 
CNR Patent:
 
IT Patent No RM2010A000015 - 20/01/2010 – US Patent 13/522642 - 20/01/2011.
Assegnees: Istituti Fisioterapici Ospitalieri, Consiglio Nazionale delle Ricerche,Universita' degli Studi di Roma "La Sapienza”   
Inventors Chessa Luciana (La Sapienza), Cundari Enrico (CNR), Prodosmo Andrea, Soddu Silvia (IFO)
Title: “Metodo per l'identificazione in vitro di portatori sani di atassia telangiectasia e relativo kit.” 



Dr. Patrizia Lavia
 
PCT WO2011/121529°1 (International publication date 06-10-2011)
Owners: CNR (17%), Sapienza Università di Roma (83%)
Inventors: Romano Silvestri, Sapienza Università di Roma; Giuseppe La Regina, Sapienza Università di Roma; Ernest Hamel, National Cancer Institute, Frederick MD, USA; Andrea Brancale, Cardiff University, UK; Patrizia Lavia, CNR; Ettore Novellino, Università di Napoli Federico II
Title: “Indolic derivatives and use thereof in medical field”.